Patents by Inventor Philippe Hermand
Philippe Hermand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140099339Abstract: The present invention relates to a combination of 2 or more S pneumoniae proteins, their manufacture and use in medicine as a vaccine. Such combinations are particularly useful for the protection of infants and elderly against streptococcal infection.Type: ApplicationFiled: December 10, 2013Publication date: April 10, 2014Applicant: GLAXOSMITHKLINE BIOLOGICALS S.A.Inventors: Philippe Hermand, Craig A. J. Laferriere, Yves Lobet, Jan Poolman
-
Publication number: 20090155309Abstract: The invention relates to the use of a non-live influenza virus antigen preparation, particularly a split influenza virus preparation, in the manufacture of a vaccine formulation for a one-dose intranasal vaccination against influenza, wherein the one-dose vaccination meets international regulatory requirements for influenza vaccines. Further provided are methods for the production of the vaccine, and a pharmaceutical kit comprising an intranasal administration device and the one-dose vaccine.Type: ApplicationFiled: February 18, 2009Publication date: June 18, 2009Inventors: Martin Friede, Veronique Henderickx, Philippe Hermand, Moncef Mohamed Saloui, Sefan Gabriel Jozef Thoelen
-
Publication number: 20080311156Abstract: The present invention relates to adjuvant compositions which are suitable to be used in vaccines. In particular, the adjuvant compositions of the present invention comprises a saponin and an immunostimulatory oligonucleotide, optionally with a carrier. Also provided by the present invention are vaccines comprising the adjuvants of the present invention and an antigen. Further provided are methods of manufacture of the adjuvants and vaccines of the present invention and their use as medicaments. Methods of treating an individual susceptible to or suffering from a disease by the administration of the vaccines of the present invention are also provided.Type: ApplicationFiled: July 11, 2008Publication date: December 18, 2008Inventors: Martin FRIEDE, Nathalie Garcon, Catherine Marie Ghislaine Gerard, Philippe Hermand
-
Patent number: 7399472Abstract: The present invention relates to adjuvant compositions which are suitable to be used in vaccines. In particular, the adjuvant compositions of the present invention comprises a saponin and an immunostimulatory oligonucleotide, optionally with a carrier. Also provided by the present invention are vaccines comprising the adjuvants of the present invention and an antigen. Further provided are methods of manufacture of the adjuvants and vaccines of the present invention and their use as medicaments. Methods of treating an individual susceptible to or suffering from a disease by the administration of the vaccines of the present invention are also provided.Type: GrantFiled: March 3, 2003Date of Patent: July 15, 2008Assignee: Smithkline Beecham BiologicalsInventors: Martin Friede, Nathalie Garcon, Catherine Marie Ghislaine Gerard, Philippe Hermand
-
Publication number: 20080095788Abstract: The present invention relates to adjuvant compositions which are suitable to be used in vaccines. In particular, the adjuvant compositions of the present invention comprises a saponin and an immunostimulatory oligonucleotide, optionally with a carrier. Also provided by the present invention are vaccines comprising the adjuvants of the present invention and an antigen. Further provided are methods of manufacture of the adjuvants and vaccines of the present invention and their use as medicaments. Methods of treating an individual susceptible to or suffering from a disease by the administration of the vaccines of the present invention are also provided.Type: ApplicationFiled: December 20, 2007Publication date: April 24, 2008Inventors: Martin Friede, Nathalie Garcon, Catherine Gerard, Philippe Hermand
-
Publication number: 20080081050Abstract: The present invention relates to a combination of 2 or more S pneumoniae proteins, their manufacture and use in medicine as a vaccine. Such combinations are particularly useful for the protection of infants and elderly against streptococcal infection.Type: ApplicationFiled: May 7, 2007Publication date: April 3, 2008Inventors: Philippe Hermand, Craig Laferriere, Yves Lobet, Jan Poolman
-
Publication number: 20050201946Abstract: Aminopiperidine derivatives and pharmaceutically acceptable derivatives thereof are disclosed. Such derivatives are useful in methods of treatment of bacterial infections in mammals, particularly in man.Type: ApplicationFiled: May 2, 2005Publication date: September 15, 2005Inventors: Martin Friede, Veronique Henderickx, Philippe Hermand, Moncef Slaoui, Stefan Thoelen
-
Publication number: 20050004915Abstract: A method generates names that are different from those comprised in a set of existing names. A set of patterns is provided and one of the patterns of the set is selected. The pattern is then actualized to provide a list of candidate names. The list of candidate names is then filtered against the set of existing names to provide names, which are different from those comprised in the set of existing names. The method makes it possible to generate domain names, uniform resource locators, trademarks or the like.Type: ApplicationFiled: May 21, 2003Publication date: January 6, 2005Inventor: Jean-Philippe Hermand
-
Publication number: 20040081662Abstract: The present invention relates to a combination of 2 or more S pneumoniae proteins, their manufacture and use in medicine as a vaccine. Such combinations are particularly useful for the protection of infants and elderly against streptococcal infection.Type: ApplicationFiled: October 8, 2003Publication date: April 29, 2004Inventors: Philippe Hermand, Craig A.J. Laferriere, Yves Lobet, Jan Poolman
-
Publication number: 20030161834Abstract: The present invention relates to adjuvant compositions which are suitable to be used in vaccines. In particular, the adjuvant compositions of the present invention comprises a saponin and an immunostimulatory oligonucleotide, optionally with a carrier. Also provided by the present invention are vaccines comprising the adjuvants of the present invention and an antigen. Further provided are methods of manufacture of the adjuvants and vaccines of the present invention and their use as medicaments. Methods of treating an individual susceptible to or suffering from a disease by the administration of the vaccines of the present invention are also provided.Type: ApplicationFiled: March 3, 2003Publication date: August 28, 2003Applicant: SmithKline Beecham Biologicals s.a.Inventors: Martin Friede, Nathalie Garcon, Catherine Marie Ghislaine Gerard, Philippe Hermand
-
Patent number: 6558670Abstract: The present invention relates to adjuvant compositions which are suitable to be used in vaccines. In particular, the adjuvant compositions of the present invention comprises a saponin and an immunostimulatory oligonucleotide, preferably the saponins used in said adjuvant combinations are haemolytic. Also provided by the present invention are vaccines comprising the adjuvants of the present invention and an antigen. Further provided are methods of manufacture of the adjuvants and vaccines of the present invention and their use as medicaments.Type: GrantFiled: April 29, 1999Date of Patent: May 6, 2003Assignee: SmithKline Beechman Biologicals s.a.Inventors: Martin Friede, Philippe Hermand
-
Patent number: 6544518Abstract: The present invention relates to adjuvant compositions which are suitable to be used in vaccines. In particular, the adjuvant compositions of the present invention comprises a saponin and an immunostimulatory oligonucleotide, optionally with a carrier. Also provided by the present invention are vaccines comprising the adjuvants of the present invention and an antigen. Further provided are methods of manufacture of the adjuvants and vaccines of the present invention and their use as medicaments. Methods of treating an individual susceptible to or suffering from a disease by the administration of the vaccines of the present invention are also provided.Type: GrantFiled: October 18, 2000Date of Patent: April 8, 2003Assignee: SmithKline Beecham Biologicals s.a.Inventors: Martin Friede, Nathalie Garcon, Catherine Marie Ghislaine Gerard, Philippe Hermand